Resource Library

Improving Hormonal Contraceptive Supply: The Potential Contribution of Manufacturers of Generic and Biosimilar Drugs

Research and development (R&D) companies dominate both the public- and private-sector markets in developing countries, despite the growing number of manufacturers able to produce low-cost generic and biosimilar products around the world. This paper describes the different types of hormonal-contraceptive manufacturers and opportunities for increased competition from generic and biosimilar suppliers in the procurement field, as well as the commercial sector. Barriers addressed in the paper include the difficulty of monitoring product quality and safety in developing countries, the limited sales and marketing capability of local manufacturers, unfavorable procurement policies, and market distortions caused by well-meaning donor-funded programs. Give us feedback! Is this technical research report useful to you? We'd appreciate feedback, so please share your thoughts with us on our Q&A board.